Vaccine
Prevented Illnesses (Photos)

This child
with MEASLES, displays the
characteristic red, blotchy pattern on his face and body during
the third day of the rash. Immunization has decreased the
incidence of measles in the U.S. by 99 percent, though outbreaks
in 2008 have resulted from non-immunized people acquiring the
infection while traveling abroad. Measles is highly contagious.
Measles typically results in rash, fever and cough.
Complications can include ear infection, croup, diarrhea and,
rarely, encephalitis and death.
Photo source: U.S. Centers for
Disease Control and Prevention
One of the most infectious diseases in
the world; if measles vaccinations were stopped, it is estimated
that 2.7 million people would die worldwide.
How it spreads: Coughing, sneezing,
talking.

A patient
displays swelling due to MUMPS,
a
disease that is characterized by swelling of the salivary
glands. Prior to the vaccine that was introduced in 1967, an
estimated 100,000 to 200,000 cases of mumps occurred in the U.S.
each year.
Photo source: U.S. Centers for Disease Control and Prevention.
Before the vaccine, mumps was a major
cause of deafness and brain damage in children.
How it spreads: Coughing,
sneezing, talking.

A young boy
displays the characteristic rash indicative of
RUBELLA, otherwise known as German
measles. Rubella is a respiratory viral infection characterized
by mild respiratory symptoms and low-grade fever, followed by a
rash lasting about 3 days. In children, the illness may not be
diagnosed since the rash may be mild and mimic other conditions.
Rubella vaccination is particularly important for non-immune
women who may become pregnant because of the risk for serious
birth defects if they acquire the disease during pregnancy.
Birth defects include deafness, cataracts, heart defects, mental
retardation, and liver and spleen damage (at least a 20% chance
of damage to the fetus if a woman is infected early in
pregnancy).
Photo source: U.S. Centers for Disease Control and Prevention
During 1964 and 1965, before the
vaccine, of the 20,000 infants born with rubella syndrome,
11,600 were deaf, 3580 were blind, and 1800 were mentally
retarded.
How it spreads: Coughing or
sneezing.
This child with
DIPHTHERIA presented with a characteristic swollen
neck, sometimes referred to as “bull neck”.
Photo source: U.S. Centers for Disease Control and Prevention
Before the vaccine, diphtheria caused as
many as 15,520 deaths in children during one year.
How it spreads: Direct contact
with an infected person.
It can lead to breathing problems, heart
failure, and death.

A
preschool-aged boy displays the severe muscle contraction of
TETANUS, a disease caused by
bacteria in a dirt-contaminated wound. Deep-puncture wounds pose
the biggest risk.
Photo source: U.S. Centers for Disease Control and Prevention
Without a vaccine, persons of all ages
in the US could get this deadly disease.
How it spreads: Lives in the soil
and enters the body through cuts and puncture wounds.
Tetanus is NOT contagious from person to person.
It can lead to stiffness of the jaw, so
the victim can't open his mouth or swallow. It leads to
death in about 1 case out of 5.

A
preschool-aged boy with PERTUSSIS
(whooping cough) produced thick, respiratory secretions
during a severe coughing spell. Pertussis is most severe when it
occurs in the first six months of life.
Photo source: AAP Red Book Online Visual Library
Before the vaccine, between 150,000 and
260,000 cases of pertussis and up to 9000 deaths were reported
each year.
How it spreads: Coughing and
sneezing, highly contagious.
It can lead to pneumonia, seizures
(jerking and staring spells), brain damage and death.
According to a CDC study, parents and
siblings are important contributors to the spread of pertussis
infection to infants and young children.
Adults who have not had a tetanus
booster in the last five years should ask their physician about
receiving this important vaccine.
Child has swollen face due to
HIB (Haemophilus influenzae
type b) infection.
Photo source: U.S. Centers for Disease Control and Prevention.
Before the vaccine, Hib meningitis
killed 600 children each year and left many survivors with
deafness, seizures or mental retardation.
How it spreads: Contact with an
infected person; enters through the nose and throat.
It can lead to meningitis; pneumonia;
infections of the blood, joints, bones and covering of the
heart; brain damage; deafness; and death.

Made of
stainless steel, this Emerson Respirator, also known as an "iron
lung," was used by POLIO patients
whose ability to breathe was stopped by the crippling viral
disease. This iron lung was donated to the CDC's Global Health
Odyssey by the family of polio patient Barton Hebert of
Covington, La., who had used the device from the late 1950s
until his death in 2003. Iron lungs encase the chest cavity in
an air-tight chamber. The chamber is used to create a negative
pressure around the body, causing air to rush into the lungs.
Photo source: U.S. Centers for Disease Control and Prevention
This child
is displaying a deformity of her right leg due to
POLIO.
Photo source: U.S. Centers for Disease Control and Prevention
Before the vaccine, 13,000 to 20,000
cases of paralytic polio were reported each year in the US; many
children were left on crutches, in braces, in wheelchairs, an on
iron lungs.
How it spreads: Transmitted by
person-to-person contact with contaminated water. Some
people experience no symptoms at all but are carriers who can
spread the disease to others.
It can lead to paralysis; or death (by
paralyzing breathing muscles).
A teenage
girl is pictured with VARICELLA
(chickenpox) lesions in various stages. Chickenpox tends
to be more severe in adolescents and adults than in young
children.
Photo source: AAP Red Book Online Visual Library

This
10-year-old, unvaccinated boy developed
VARICELLA (chickenpox) with hemorrhagic lesions.
Photo source: AAP Red Book Online Visual Library
Before the vaccine, an estimated 4
million people got chickenpox, causing 11,000 hospitalizations
and 100 deaths each year.
How it spreads: Coughing,
sneezing, or contact with chickenpox sores; usually occurs in
children younger than 10 years of age.
HEPATITIS B
(no available photo)
Approximately 25% of children who
develop lifelong hepatitis B infection die of related liver
disease as adults.
How it spreads: Direct contact
with infected blood; via blood transfusions, other body fluids
and sexual transmission. It can also be contracted through
tatooing and body piercing. A pregnant woman who is
infected can also infect her baby.
It can lead to liver damage; liver
cancer and death.
HEPATITIS A (no available
photo)
Hepatitis A is a contagious
liver infection caused by the hepatitis A virus. Symptoms can include fever,
tiredness, poor appetite, vomiting, stomach pain, and sometimes jaundice (when
skin and eyes turn yellow). Hepatitis A virus is found in large quantities in
the feces (or stool) of an infected person. Hepatitis A is spread by contact
with people who are infected or through contact with contaminated objects such
as food or water.
Vaccinate with hepatitis
A vaccine between 12 and 23 months (2 doses).
PNEUMOCOCCUS
(no available photo)
Before the vaccine, about 188 of every
100,000 children younger than 2 years of age developed invasive
pneumococcal disease.
How it spreads: Coughing and
sneezing.
It can lead to meningitis; blood
infections, ear infections, pneumonia, deafness, brain damage
and death.
ROTAVIRUS
(no available photo)
Rotavirus is the leading cause of severe acute
gastroenteritis (vomiting and severe diarrhea) among
children worldwide. Two different rotavirus vaccines
are currently licensed for use in infants in the
United States. The vaccines are RotaTeq® (RV5) and
Rotarix® (RV1). Before being licensed, both vaccines
were tested in clinical trials and shown to be safe
and effective. In these studies, during
approximately the first year of an infant’s life,
rotavirus vaccine was found to prevent almost all
(85%-98%) rotavirus illness episodes that were
severe and to prevent 74%-87% of all rotavirus
illness episodes.
Signs and symptoms include: severe
diarrhea, vomiting and fever.
How it spreads: Contact with other
children who are infected.
It can lead to dehydration,
hospitalization (up to about 70,000 per year), and death.

4 month old female with gangrene of hands
due to MENINGOCOCCEMIA
In 2004, an estimated 125 deaths due to
meningococcal disease occurred in the US. Infants younger
than 12 months of age have the highest rates of disease.
Meningococcal meningitis
A common outcome of meningococcus infection
is meningitis. When caused by Neisseria
meningitidis it is known as meningococcal
meningitis or bacterial meningitis. When someone
has meningococcal meningitis, the protective
membranes covering their brain and spinal cord,
known as the meninges, become infected and
swell. This is characterized by a sudden
onset of fever, headache, and stiff neck. It
is often accompanied by other symptoms, such as
- Nausea
- Vomiting
- Photophobia (sensitivity to light)
- Altered mental status
The symptoms of meningococcal meningitis can
appear quickly or over several days. Typically
they develop within three to seven days after
exposure.
Meningococcal meningitis can be fatal and
should always be viewed as a medical emergency.
About ten percent of infected people die from
the disease. In non-fatal cases, those affected
experience long-term disabilities, such as brain
damage, loss of limb, or deafness. Preventing
the disease through the use of meningococcal
vaccine is important.
Meningococcal septicemia
Another common outcome of meningococcus
infection is meningococcemia, also known as
meningococcal septicemia. This is the more
dangerous and deadly of illnesses caused by
Neisseria meningitidis. When Neisseria
meningitidis bacteria enter the bloodstream
and multiply, they damage the walls of the blood
vessels and cause bleeding into the skin and
organs.
Symptoms may include fever, fatigue,
vomiting, cold hands and feet, cold chills,
severe aches or pain in the muscles, joints,
chest or abdomen, rapid breathing, diarrhea —
and, in the later stages, a puerperal rash or a
petechial rash. Even with antibiotic treatment,
people die in about 10-15 percent of cases
How it spreads: Contact with
infected individual through throat (coughing and kissing).
The bacteria are not spread by casual contact or by simply
breathing the air where a person with meningococcal disease has
been.